Institutional members access full text with Ovid®

Share this article on:

An Open Letter to the US Food and Drug Administration Regarding the Value of Electroconvulsive Therapy

McCall, W. Vaughn MD, MS

doi: 10.1097/YCT.0b013e31821f9acf
Editorial

From the Wake Forest University Baptist Medical Center, Winston-Salem, NC (e-mail: vmccall@wfubmc.edu).

Received for publication April 13, 2011; accepted April 13, 2011.

© 2011 Lippincott Williams & Wilkins, Inc.